Chong (second right) and other directors from Topvision and HLIB during the prospectus launch.
KUALA LUMPUR (Nov 25): A new centre in Tawau, Sabah are among the future plans of medical eye care service provider TOPVISION Eye Specialist Berhad (Topvision) following the launch of its prospectus for the upcoming public offering in conjunction with Topvision’s transfer of listing from the LEAP Market to the ACE Market of Bursa Malaysia.
This move underscores its continuous commitment to delivering high-quality eye healthcare nationwide as well as boosts Topvision’s public market visibility.
This public Offering aims to raise RM17.89 million through the issuance of 54.22 million new ordinary shares at a retail price of RM0.33 per share.
The funds raised from this exercise will be allocated RM7.90 million for the establishment of the Topvision International Eye Specialist Centre in Klang Valley, a tertiary eye ambulatory care centre with subspecialty services like retinal surgery, cornea transplants, and paediatric ophthalmology to meet patient needs and elevate eye healthcare standards.
Meanwhile, RM5 million for expanding the ACC network with new centres in Kuala Terengganu and Tawau, Sabah, expanding Topvision’s presence in East Malaysia and enhancing access to quality eye care.
RM0.50 million is allotted for the purchase of machines, including phacoemulsification machines to improve service quality across Topvision’s network, while RM4.50 million will be used listing expenses for the transfer of listing from the LEAP Market to the ACE Market of Bursa Securities.
Its chief executive officer and executive director Dr Peter Chong Kuok Siong said, “We are thrilled to launch our prospectus, marking Topvision’s another milestone in the process of transfer its listing to the ACE Market.
“This move not only accelerates our growth but underscores our commitment to advancing eye healthcare across Malaysia. With funds raised, we will expand our ACC network, establish Topvision International, and invest in new machines, all aimed at enhancing patient care.
“This listing reflects our dedication to sustainable growth, clinical excellence, and our mission to improve the quality of life for our patients.”
Hong Leong Investment Bank Berhad is the principal adviser, sponsor, sole underwriter and sole bookrunner.
The post Sabah centre among future plans after Topvision’s transfer of listing appeared first on Borneo Post Online.